Your browser doesn't support javascript.
loading
Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector.
Smith, Eric L; Staehr, Mette; Masakayan, Reed; Tatake, Ishan J; Purdon, Terence J; Wang, Xiuyan; Wang, Pei; Liu, Hong; Xu, Yiyang; Garrett-Thomson, Sarah C; Almo, Steven C; Riviere, Isabelle; Liu, Cheng; Brentjens, Renier J.
Afiliação
  • Smith EL; Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Staehr M; Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Masakayan R; Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tatake IJ; Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Purdon TJ; Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wang X; Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wang P; Eureka Therapeutics, Emeryville, CA, USA.
  • Liu H; Eureka Therapeutics, Emeryville, CA, USA.
  • Xu Y; Eureka Therapeutics, Emeryville, CA, USA.
  • Garrett-Thomson SC; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Almo SC; Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Riviere I; Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Liu C; Eureka Therapeutics, Emeryville, CA, USA.
  • Brentjens RJ; Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: brentjer@mskcc.org.
Mol Ther ; 26(6): 1447-1456, 2018 06 06.
Article em En | MEDLINE | ID: mdl-29678657

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Antígeno de Maturação de Linfócitos B / Anticorpos de Cadeia Única Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Antígeno de Maturação de Linfócitos B / Anticorpos de Cadeia Única Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article